Hopp til innhold
NHI.no
Annonse

Henoch Schønleins purpura: Årsak

Tilstanden har ingen klar årsak, men kommer ofte en tid etter en øvre luftveisinfeksjon (f.eks. halsinfeksjon). Den kan også utløses av medikamenter, inkludert antibiotika. Antistoffer produsert av immunsystemet er involvert. Det skapes en betennelsesreaksjon i de små blodårene som fører til lekkasje av væske og blod ut av blodårene, noe som gir symptomer i ulike organsystemer.

Annonse

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Henoch-Schønleins purpura . Referanselisten for dette dokumentet vises nedenfor

  1. Søreide K, Ansorge C, Øgreid P. Skrotal smerte og Henoch-Schönleins purpura. Tidsskr Nor Lægeforen 2004; 124: 335-6. Tidsskrift for Den norske legeforening
  2. Roberts PF, Waller TA, Brinker TM, et al. Henoch-Schonlein purpura: a review article. South Med J. 2007;100:821-824. PubMed
  3. Ozen S, Pistorio A, Iusan SM, et al; Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 2010;69:798-806. PubMed
  4. Saulsbury FT. Clinical update: Henoch-Schönlein purpura. Lancet 2007; 369: 976-8. PubMed
  5. Trapani S, Micheli A, Grisolia F, et al. Henoch-Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 2005; 35: 143-53. PubMed
  6. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood T. Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002; 360: 1197 - 202. PubMed
  7. Gedalia A. Henoch-Schönlein purpura. Curr Rheumatol Rep 2004; 6: 195-202. PubMed
  8. Reamy BV, Williams PM, Lindsay TJ. Henoch-Schönlein purpura. Am Fam Physician 2009; 80: 697-704. American Family Physician
  9. Masuda M, Nakanishi K, Yoshizawa N, Iijima K, Yoshikawa N. Group A streptococcal antigen in the glomeruli of children with Henoch-Schönlein nephritis. Am J Kidney Dis 2003; 41: 366-70. PubMed
  10. Roberts PF. Henoch-Schonlein purpura. BestPractice, last updated April 16, 2014.
  11. Ben-Sira L, Laor T. Severe scrotal pain in boys with Henoch-Schönlein purpura: incidence and sonography. Pediatr Radiol 2000; 30: 125 - 8. PubMed
  12. Ioannides AS, Turnock R. An audit of the management of the acute scrotum in children with Henoch-Schonlein purpura. J R Coll Surg Edinb 2001; 46: 98 - 9. PubMed
  13. Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 2005; 90: 916-20. PMID: 15871983 PubMed
  14. Kellerman PS. Henoch-Schönlein purpura in adults. Am J Kidney Dis 2006; 48: 1009-16. PubMed
  15. Shin JI, Park JM, Shin YH, Hwang DH, Kim JH, Lee JS. Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schönlein purpura. Scand J Rheumatol 2006; 35: 56-60. PubMed
  16. Coppo R, Andrulli S, Amore A, et al. Predictors of outcome in Henoch-Schönlein nephritis in children and adults. Am J Kidney Dis 2006; 47: 993-1003. PubMed
  17. Norsk barnelegeforening. Henoch-Schönleins purpura (HSP). Akuttveileder i pediatri. Sist revidert 2012. Siden lest 11.02.2019. www.helsebiblioteket.no
  18. Haroon M. Should children with Henoch-Schonlein purpura and abdominal pain be treated with steroids? Arch Dis Child 2005;90:1196-1198. PubMed
  19. Ronkainen J, Ala-Houhala M, Huttunen NP, et al. Outcome of Henoch-Schoenlein nephritis with nephrotic-range proteinuria. Clin Nephrol 2003; 60: 80-4. PubMed
  20. Ronkainen J, Koskimies O, Ala-Houhala M, et al. Early prednisone therapy in Henoch-Schonlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 2006; 149: 241-7. PubMed
  21. Weiss PF, Feinstein JA, Luan X, Burnham JM, Feudtner C. Effects of corticosteroid on Henoch-Schönlein purpura: a systematic review. Pediatrics 2007; 120: 1079-87. Pediatrics
  22. Zaffanello M, Brugnara M, Franchini M. Therapy for children with Henoch-Schönlein purpura nephritis: a systematic review. ScientificWorldJournal 2007; 7 :20-30.
  23. Chartapisak W, Opastiraku S, Willis NS, Craig JC, Hodson EM. Prevention and treatment of renal disease in Henoch-Schönlein purpura: a systematic review. Arch Dis Child 2009; 94: 132-7. PubMed
  24. Calvo-Rio V, Lociera J, Mata C, et al. Henoch-Schönlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center. Medicine (Baltimore) 2014; 93: 106-13. pmid:24646467 PubMed
  25. Narchi H. Risk of long-term renal impairment and duration of follow up recommended for Henoch-Schönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 2005; 90: 916-20. PubMed
  26. Sano H, Izumida M, Shimizu H, Ogawa Y. Risk factors of renal involvement and significant proteinuria in Henoch-Schonlein purpura. Eur J Pediatr 2002; 161: 196 - 201. PubMed
  27. Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective cohort study. Lancet 2002; 369: 666 - 70. PubMed
  28. Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 2005; 90: 916-20. PubMed
Annonse
Annonse